A role for natriuretic peptides as well as endothelins in the hypoxic lungs of patients with chronic obstructive pulmonary disease.

A role for natriuretic peptides as well as endothelins in the hypoxic lungs of patients with chronic obstructive pulmonary disease.

Bibliographic Details
Main Author:	Dorrington, K
Format:	Journal article
Language:	English
Published:	1999

Similar Items

Natriuretic peptides in elderly patients with chronic obstructive pulmonary disease
by: Bodrug Nicolae, et al.
Published: (2022-05-01)

Can intravenous endothelin-1 be used to enhance hypoxic pulmonary vasoconstriction in healthy humans?
by: Talbot, N, et al.
Published: (2008)

Role of N-terminal pro B-type natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease
by: Hatem El Mallawany, et al.
Published: (2014-01-01)

Prognostic value of plasma brain natriuretic peptide in patients with stable chronic obstructive pulmonary disease
by: Ahmed E. Mansour, et al.
Published: (2012-10-01)

Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease
by: Nishimura K, et al.
Published: (2014-02-01)

Phosphoramidon augments hypoxic pulmonary vasoconstriction in the isolated perfused rabbit lung.
by: Mundy, A, et al.
Published: (1999)

Use of brain natriuretic peptide to detect previously unknown left ventricular dysfunction in patients with acute exacerbation of chronic obstructive pulmonary disease
by: K Gariani, et al.
Published: (2011-11-01)

Role of endothelin-1 in lung disease
by: Rodman David M, et al.
Published: (2001-02-01)

Natriuretic peptides in diagnosis of pulmonary hypertension
by: Anna Viktorovna Kuznetsova, et al.
Published: (2009-09-01)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
by: Héctor Fernández‐Susavila, et al.
Published: (2017-12-01)

Clinical value of natriuretic peptides in chronic kidney disease
by: Carla Santos-Araújo, et al.
Published: (2015-05-01)

Clinical value of natriuretic peptides in chronic kidney disease
by: Carla Santos-Araújo, et al.
Published: (2015-05-01)

Intense slow hypoxic pulmonary vasoconstriction in gas-filled and liquid-filled lungs: an in vivo study in the rabbit.
by: Vejlstrup, N, et al.
Published: (1993)

Optimizing Wellness in Chronic Obstructive Pulmonary Disease
by: Roger S Goldstein, et al.
Published: (2007-01-01)

Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)
by: Franziska C. Trudzinski, et al.
Published: (2024-07-01)

Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role
by: N A Mukhin, et al.
Published: (2009-03-01)

Elevated plasma levels of endothelin are associated with the severity of sepsis and presence of shock in contrast to the levels of atrial natriuretic peptide
by: A. Beishuizen, et al.
Published: (1992-01-01)

Effect of acupuncture on the genetic expression of myocardial endothelin-1 and atrial natriuretic peptide in rats with stress-induced prehypertension
by: Wenrui Jia, et al.
Published: (2017-01-01)

EFFECT OF LUNG-INFLATION ON THE TIME-COURSE OF SLOW HYPOXIC PULMONARY VASOCONSTRICTION (HPV) IN THE ANESTHETIZED RABBIT
by: Vejlstrup, N, et al.
Published: (1994)

Natriuretic Peptides in Chronic Heart Failure
by: Hans-Peter Brunner-La Rocca, et al.
Published: (2019-01-01)

Hypoxic pulmonary vasoconstriction: Evidence in humans of a role for hypoxia inducible factor.
by: Balanos, G, et al.
Published: (2001)

Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease
by: Lei Wang, et al.
Published: (2017-01-01)

The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension.
by: Yap, L, et al.
Published: (2004)

Role of endothelin in lung fibrosis
by: D. Abraham
Published: (2008-12-01)

A song of iron and oxygen: Hypoxic pulmonary vasoconstriction and gas exchange in chronic obstructive pulmonary disease
by: Jacob P. Hartmann, et al.
Published: (2023-04-01)

Peptides in Bronchoalveolar Lavage in Chronic Obstructive Pulmonary Disease.
by: Chris H Wendt, et al.
Published: (2016-01-01)

Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases
by: Hitoshi Nakagawa, et al.
Published: (2022-07-01)

Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea—a prospective intervention study
by: Meropi Karakioulaki, et al.
Published: (2021-04-01)

A cell permeable peptide targeting the intracellular loop 2 of endothelin B receptor reduces pulmonary hypertension in a hypoxic rat model.
by: Daniel S Green, et al.
Published: (2013-01-01)

Study of the Effect of Treatment With Atrial Natriuretic Peptide (ANP) and Cinaciguat in Chronic Hypoxic Neonatal Lambs on Residual Strain and Microstructure of the Arteries
by: Alvaro Navarrete, et al.
Published: (2020-11-01)

Endothelins: Vasoactive Peptids
by: Hasan Erdoğan, et al.
Published: (2013-08-01)

Polycythemia in dogs with chronic hypoxic pulmonary disease
by: Saila Holopainen, et al.
Published: (2022-07-01)

Lung Compliance and Chronic Obstructive Pulmonary Disease
by: D. Papandrinopoulou, et al.
Published: (2012-01-01)

Lung transplantation for chronic obstructive pulmonary disease
by: Liou TG, et al.
Published: (2013-07-01)

Natriuretic Peptides
by: Selim Demirtaş, et al.
Published: (2014-12-01)

Chronic obstructive pulmonary disease phenotype desaturator with hypoxic vascular remodelling and pulmonary hypertension obtained by cluster analysis
by: Toraldo Domenico, et al.
Published: (2012-11-01)

Roles of Mesenchymal Cells in the Lung: From Lung Development to Chronic Obstructive Pulmonary Disease
by: Amel Nasri, et al.
Published: (2021-12-01)

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease
by: Wang W, et al.
Published: (2023-02-01)

Probable role of Brain Natriuretic Peptide (BNP) in lung hypertension secondary to scleroderma
by: P. Faggioli, et al.
Published: (2013-05-01)

Natriuretic peptide system and cardiovascular disease
by: Federico Cacciapuoti
Published: (2010-01-01)